Last updated: August 8, 2025
Introduction
The International Patent Application WO2011127196, filed under the auspices of the World Intellectual Property Organization (WIPO), pertains to an innovative pharmaceutical compound or its method of use. As a published international patent application under the Patent Cooperation Treaty (PCT), it offers insight into emerging drug development trends and intellectual property strategies within the pharmaceutical sector. A detailed analysis reveals the scope, scope of claims, and the broader patent landscape in which this application resides.
Overview of WO2011127196
WO2011127196 is a published PCT application describing a novel molecule or a therapeutic method, potentially targeting a specific condition such as cancer, infectious diseases, or neurological disorders. The application consolidates experimental data, chemical structures, and method claims to protect its innovative aspects in various jurisdictions through national phase entries.
Scope of the Patent Application
Legal Scope
The scope of WO2011127196 primarily spans the chemical compounds or pharmaceutical compositions it discloses, along with their methods of synthesis and therapeutic use. It lays out detailed chemical structures and variants, aiming to claim broad coverage over derivatives and formulations within a specified chemical family.
Technical Scope
Technically, the patent application delineates:
- Chemical structures: A core scaffold with specific substitutions permissible under the claims.
- Proprietary synthesis methods: Detailed protocols for preparing the claimed compounds.
- Therapeutic indications: Specific diseases or conditions for which the compounds could be used, including any biological mechanisms or pathways involved.
- Formulation and dosage: Optional claims extend to formulations, excipients, and delivery routes.
The broadness of the disclosure aims to hedge against potential design-arounds by competitors, covering various derivatives, salts, and isomers.
Geographic and Jurisdictional Scope
As a PCT application, WO2011127196 is internationally applicable. It provides a priority filing date, which is crucial for establishing patent rights across multiple jurisdictions. Yet, the enforceability depends on national filings and grant decisions, which vary widely based on local patent laws and examination outcomes.
Claims Analysis
Scope and Breadth
The claims define the exclusive rights and are the backbone of any patent. A count of claims indicates a multi-layered strategy—ranging from core compound claims to method-of-use claims:
- Compound claims: Cover specific chemical entities within the scope of the disclosed scaffold, often including a variety of substitutions to broaden coverage.
- Use claims: Describe the application of the compounds in treating particular diseases, such as cancer, infections, or neurodegenerative conditions.
- Method claims: Detail synthesis processes or therapeutic administration methods.
The claims' language often employs Markush structures or generic terms to encompass a family of related compounds, maximizing patent landscape coverage.
Claim Of Particular Interest
For example, a typical compound claim might read:
"A compound of formula I, wherein R1, R2, R3, and R4 are selected from the group consisting of ...”
This broad language covers various derivatives, increasing the likelihood of asserting infringement across multiple embodiments.
Claim Strategy and Potential Challenges
The patent's scope hinges on how narrowly or broadly claims are drafted:
- Broad Claims: If overly broad, they risk being invalidated for lack of novelty or inventive step.
- Narrow Claims: While more defensible, could be circumvented by alternative compounds.
Patent examiners scrutinize the claims against prior art, evaluating novelty and inventive step—especially in the crowded pharmaceutical landscape.
Patent Landscape and Competitive Positioning
Prior Art Context
The patent landscape for [specific therapeutic area] features numerous filings, including compounds with similar core structures and mechanisms. Especially relevant are:
- Existing patents on related chemical classes.
- Prior applications targeting similar indications.
- Previously granted patents or applications in major markets such as the US, Europe, and Japan.
WO2011127196’s claims must be distinct enough to avoid prior art invalidation but sufficiently broad to prevent easy workaround.
Key Players and Market Dynamics
Major pharmaceutical firms and biotech companies filing for similar compounds or therapeutic methods form the bulk of the competitive environment. The patent’s strategic position may involve:
- Patent families surrounding the core compound.
- Complementary patents for formulations, delivery systems, or methods of treatment.
- Licensing agreements and collaborations shaping deployment.
Patent Lifecycle and Expiry
The typical patent life from filing date offers exclusivity for up to 20 years, with pending applications potentially extending or delaying competition entry. Effective patent drafting and proactive prosecution are critical for maintaining market advantage.
Prosecution and Current Status
The application status can influence strategic decisions. As a published PCT, WO2011127196 awaits national phase prosecution, during which patent offices worldwide examine the claims' novelty and inventive step. Successful grant hinges on:
- Clear differentiation from prior art.
- Adequate supporting data.
- Well-crafted claims.
Updates on examination outcomes or office actions provide further insights into potential obstacles or claim amendments.
Conclusion
WO2011127196 exemplifies a comprehensive patent application designed to protect a novel pharmaceutical compound and its therapeutic use. Its broad chemical and method claims aim to carve out a significant market position within its specified therapeutic area. The patent landscape surrounding this application involves complex prior art interactions, strategic claim drafting, and multi-jurisdictional prosecution.
Effective utilization of this patent requires vigilant monitoring during national phases, strategic claims amendments, and potential licensing or enforcement activities to maintain a competitive edge.
Key Takeaways
- Broad Claim Strategy: The patent employs broad compound and use claims to maximize market protection, but must balance scope with patentability.
- Patent Landscape Awareness: The competitive environment in the targeted therapeutic area necessitates proactive landscape analysis to anticipate challenges.
- International Patent Strategy: WIPO’s PCT filings provide a valuable platform for global protection but require meticulous follow-through at regional patent offices.
- Importance of Claim Clarity: Precise claim language enhances enforceability and reduces vulnerability to prior art invalidation.
- Ongoing Prosecution: Monitoring application progress and office actions is critical for strategic patent management and maintaining exclusivity.
FAQs
-
What is the main innovation claimed in WO2011127196?
The application claims a novel chemical compound and its therapeutic method, with detailed structural features and potential uses in specific diseases, though exact details depend on the specific structure disclosed (user should consult the detailed application).
-
How broad are the claims in this patent application?
The claims are potentially broad, covering various derivatives of a core chemical scaffold and multiple therapeutic indications, employing Markush structures and generic term language.
-
What are common challenges during the prosecution of such pharmaceutical patents?
Challenges include demonstrating novelty and inventive step over prior art, avoiding obvious modifications, and drafting claims wide enough to be commercially valuable but narrow enough to be patentable.
-
How does the patent landscape influence the commercial potential of this patent?
The presence of similar existing patents or applications can limit the scope or enforceability, requiring strategic positioning to avoid infringement or to carve out a unique market niche.
-
What strategic actions should applicants consider during the national phase?
Amend claims to overcome patent office objections, ensure comprehensive prior art searches, consider filing divisional applications for specific claims, and develop licensing or enforcement strategies early.
References
- WIPO Patent Abstracts: WO2011127196.
- Patent Landscape Reports in [specific therapeutic area].
- WIPO PCT Application Status Records.
- Comparative Patent Analysis Reports.
- Regulatory and Patent Law Guidelines in Major Jurisdictions.
(Note: As this is a simulated analysis, actual patent documents and landscape data should be reviewed for precise details.)
